Market Tracker

07/22 5:16pm ET

Biogen Inc (NASDAQ:BIIB)

287.78
Delayed Data
As of Jul 22
 +5.33 / +1.89%
Today’s Change
223.02
Today|||52-Week Range
401.11
-6.06%
Year-to-Date
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content
15 Biggest Mid-Day Gainers For Thursday
Jul 21 / Benzinga - Paid Partner Content
Biogen (BIIB) Stock Up on CEO Transition, Fueling Sale Speculation
Jul 22 / TheStreet.com - Paid Partner Content
3 Stocks Driving The Drugs Industry Higher
Jul 21 / TheStreet.com - Paid Partner Content
Biogen Should Either a Buyer or a Seller Be
Jul 22 / TheStreet.com - Paid Partner Content
Evercore's Schoenebaum Explains Biotech Boom on CNBC
Jul 21 / TheStreet.com - Paid Partner Content
Biogen Inc: How Double-Digit Growth Got Trumped
Jul 22 / MotleyFool.com - Paid Partner Content
Stocks at Session Lows as Winning Streak Is Threatened
Jul 21 / TheStreet.com - Paid Partner Content
Medical Stocks Reporting Early Next Week: GILD, LLY & More
Jul 22 / Zacks.com - Paid Partner Content
Stock Market News for July 21, 2016
Jul 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close282.45
Today’s open282.09
Day’s range281.38 - 290.92
Volume3,394,578
Average volume (3 months)1,859,788
Market cap$63.1B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+11.28%
Earnings growth (next 5 years)+9.50%
Revenue growth (last year)-3.87%
P/E ratio17.7
Price/Sales7.60
Price/Book6.71

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.22+0.48%
GILDGilead Sciences-0.69-0.79%
JUNOJuno Therapeutics In...+0.30+1.04%
CTLTCatalent Inc-0.45-1.82%
Data as of 4:01pm ET, 07/22/2016

Financials

Last reporting dateJuly 21, 2016
EPS forecast (this quarter)$4.68
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts